SRT2104 is primarily researched for its potential therapeutic applications, particularly in the field of aging and age-related diseases. It is being studied for its ability to activate sirtuins, a group of proteins associated with longevity and cellular health. This compound has shown promise in preclinical studies for improving metabolic function, reducing inflammation, and enhancing overall cellular resilience. Additionally, it is being explored for its potential to treat conditions such as type 2 diabetes, neurodegenerative disorders, and cardiovascular diseases. Research is ongoing to determine its efficacy and safety in human clinical trials.